North America
Europe
Denmark
France
Germany
Sweden
Switzerland
U.K.
Latin America
Asia Pacific
Argentina
Brazil
Mexico
Australia
India
Malaysia
New Zealand
Thailand
Hong Kong
Singapore
人々が製造または消費する製品についての考え方や感じ方、これがグローバル取引の形成に果たす役割、これが製品の考案・製造・販売・提供方法に与える影響を調べ、深く理解する研究。
more
ULは、4つの基本分野全体にわたる基本的な発見、試験方法、ソフトウェア、規格を通して、世界をより安全にしていくための重要な方法を示す強力な取り組みであるNew Scienceをお届けしていることを誇りとしています。
more
ビジネスユニット
インダストリーズ

ULは安全科学を専門とする世界的な独立企業で、5つの戦略事業分野において専門知識を提供しています。

ULは、多数の業界にわたる専門知識を武器に、グローバルな市場でのお客様の成功をお手伝いしています。

規格カタログ
理解規格
参加

規格や概要をキーワードから、あるいは承認や発効日でフィルタリングして検索

検索開始

UL規格が基準としてどのように機能し、消費者や企業が購入する製品やサービスに安心を提供しているかをご覧ください。

詳細

ULは、産業界、学界、そしてエンドユーザー専門家の見解を常に収集して、コンセンサスに基づく業界標準の策定に努めています。

関与

Share

FDA 510(k) third-party review

A 510(k) is a premarketing submission made to the FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent (SE), to a legally marketed device that is not subject to premarket approval (PMA). 510(k) (premarket notification) to the FDA is required at least 90 days before marketing, unless the device is exempt from 510(k) requirements.

Who has to submit a 510(k)?

Manufacturers must submit a new 510(k) when introducing a device into commercial distribution for the first time, proposing a different intended use for a medical device from that which they already have in commercial distribution, or if they wish to modify a device already on the market in a way that could significantly affect its safety or effectiveness.

What is third-party review?

To improve the efficiency of the 510(k) process, the FDA created the Accredited Persons Program, which authorized third parties to conduct the primary review of 510(k)s for most eligible devices. As an Accredited Person, UL is able to review a manufacturer's 510(k) information and offer a recommendation to the FDA as to whether the device is substantially equivalent to other legally marketed devices (predicate devices) in the United States. The FDA will then determine whether to grant market clearance. UL is accredited to review 510(k)s for all devices eligible under the Accredited Persons Program.

The UL advantage

UL has been an Accredited Person since program inception.   UL's experience in providing the 510(k) service is one reason why so many global medical device manufacturers have come to UL as their preferred 510(k) reviewer.

  • Time -- By law, the FDA must take action on a submission from an Accredited Person within 30 days compared to the 90 days the FDA can take to respond to a direct submission.
  • Money -- FDA user fees only apply for direct submissions. 
  • Expertise -- UL has completed more reviews than any other Accredited Person since program inception.

Additional Resources

  • "510(k) Accredited Persons Program" Article Reprint available for download on UL Knowledge Services Thought Leadership pages under "Health Sciences."
  • Download UL's FDA 510(k) toolkit, which contains helpful checklists and resources to help you get your 510(k) ready for submission (registration required)
  • Download white paper on the Accredited Person's Program by Harvey Rudolph, Ph.D. (registration required)